{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:06:59Z","timestamp":1767866819307,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1016\/s0006-8993(99)01063-x","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T16:05:14Z","timestamp":1027613114000},"page":"69-78","source":"Crossref","is-referenced-by-count":60,"title":["Effects of tolcapone upon soluble and membrane-bound brain and liver catechol-O-methyltransferase"],"prefix":"10.1016","volume":"821","author":[{"given":"M.A","family":"Vieira-Coelho","sequence":"first","affiliation":[]},{"given":"P","family":"Soares-da-Silva","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0006-8993(99)01063-X_BIB1","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/0006-291X(75)90833-5","article-title":"Catechol-O-methyltransferase in mouse liver plasma membranes","volume":"64","author":"Apprile","year":"1975","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB2","first-page":"95","article-title":"Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines","volume":"18","author":"Axelrod","year":"1966","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB3","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0021-9258(18)64731-3","article-title":"Enzymatic O-methylation of epinephrine and other catechols","volume":"233","author":"Axelrod","year":"1958","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB4","first-page":"103","article-title":"Immunoaffinity purification and partial amino acid sequence analysis of catechol-O-methyltransferase from pig liver","volume":"1080","author":"Bertocci","year":"1991","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/S0006-8993(99)01063-X_BIB5","first-page":"369","article-title":"Monoclonal antibodies recognizing both soluble and membrane bound catechol-O-methyltransferase","volume":"32","author":"Bertocci","year":"1990","journal-title":"J. Neural. Transm."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB6","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1073\/pnas.88.4.1416","article-title":"Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form","volume":"88","author":"Bertocci","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0006-8993(99)01063-X_BIB7","first-page":"812","article-title":"Studies on the tight-binding nature of tolcapone inhibition of soluble and membrane-bound rat brain catechol-O-methyltransferase","volume":"282","author":"Borges","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB9","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/0006-2952(75)90050-7","article-title":"Tight binding inhibitors: I. Kinetic behavior","volume":"24","author":"Cha","year":"1975","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB10","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/00002826-199417003-00006","article-title":"Improved therapy of Parkinson's disease with tolcapone, a central and peripheral COMT inhibitor with an S-adenosyl-l-methionine-sparing effect","volume":"17","author":"Da Prada","year":"1994","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.870100321","article-title":"Effects of tolcapone in Parkinson's patients taking l-dihydroxyphenylalanine\/carbidopa and selegiline","volume":"10","author":"Davis","year":"1995","journal-title":"Mov. Disord."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0009-9236(95)90035-7","article-title":"Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans","volume":"57","author":"Dingemanse","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1471-4159.1985.tb05432.x","article-title":"Soluble and particulate forms of rat catechol-O-methyltransferase distinguished by gel electrophoresis and immune fixation","volume":"44","author":"Grossman","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB14","first-page":"135","article-title":"Catechol-O-methyltransferase: pharmacological aspects and physiological role","volume":"27","author":"Guldberg","year":"1975","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB15","first-page":"184","article-title":"Nonintracellular, cell-associated O-methylation of isoproterenol in the isolated rabbit thoracic aorta","volume":"234","author":"Head","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1471-4159.1984.tb02755.x","article-title":"Characterization of membrane-bound and soluble catechol-O-methyltransferase from human frontal cortex","volume":"42","author":"Jeffrey","year":"1984","journal-title":"J. Neurochem."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB17","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0306-3623(94)90082-5","article-title":"General properties and clinical possibilities of new selective inhibitors of catechol-O-methyltransferase","volume":"25","author":"Kaakkola","year":"1994","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.44.1.77","article-title":"Effect of entacapone, a COMT inhibitor, on clinical disability and levodopa metabolism in Parkinsonian patients","volume":"44","author":"Kaakkola","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/S0006-8993(99)01063-X_BIB19","first-page":"333","article-title":"Catecholamine metabolism: basic aspects and clinical significance","volume":"37","author":"Kopin","year":"1985","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB20","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1021\/bi00013a008","article-title":"Kinetics of human soluble and membrane-bound catechol-O-methyltransferase\u2014a revised mechanism and description of the thermolabile variant of the enzyme","volume":"34","author":"Lotta","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/S0006-8993(99)01063-X_BIB21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/dna.1991.10.181","article-title":"Cloning and characterization of human placental catecol-O-methyltransferase cDNA","volume":"10","author":"Lundstr\u00f6m","year":"1991","journal-title":"DNA Cell Biol."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2165\/00023210-199401030-00002","article-title":"Clinical potential of catechol-O-methyltransferase (COMT) inhibitors as adjuvants in Parkinson's disease","volume":"1","author":"M\u00e4nnist\u00f6","year":"1994","journal-title":"CNS Drugs"},{"key":"10.1016\/S0006-8993(99)01063-X_BIB23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0165-6147(89)90075-8","article-title":"New selective COMT inhibitors: useful adjuncts for Parkinson's disease?","volume":"10","author":"M\u00e4nnist\u00f6","year":"1989","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-0773.1990.tb00756.x","article-title":"Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease","volume":"66","author":"M\u00e4nnist\u00f6","year":"1990","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB25","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/0024-3205(88)90258-5","article-title":"Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase","volume":"43","author":"M\u00e4nnist\u00f6","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-2999(94)00776-4","article-title":"Beneficial effects of co-administration of catechol-O-methyltransferase inhibitors and l-dihydroxyphenylalanine in rat models of depression","volume":"274","author":"M\u00e4nnist\u00f6","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00008877-199406000-00012","article-title":"Tolcapone: a potential new antidepressant detected in a novel animal model of depression","volume":"5","author":"Moreau","year":"1994","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB28","unstructured":"H.G. Motulsky, P. Spannard, R. Neubig, GraphPad Prisms, GraphPad Prism Software, San Diego, 1994."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(94)00682-W","article-title":"Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of l-DOPA and dopamine in rats","volume":"273","author":"Napolitano","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF00173538","article-title":"Biochemical and pharmacological properties of peripherally acting catechol-O-methyltranferase inhibitor Entacapone","volume":"346","author":"Nissinen","year":"1992","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB31","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/0024-3205(88)90330-X","article-title":"Catechol-O-methyltransferase activity in human and rat small intestine","volume":"42","author":"Nissinen","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB32","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1212\/WNL.43.12.2685","article-title":"Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa\/carbidopa action in parkinsonian patients","volume":"43","author":"Roberts","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/S0006-8993(99)01063-X_BIB33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BFb0036121","article-title":"Membrane-bound catechol-O-methyltransferase: a reevaluation of its role in the O-methylation of the catecholamine neurotransmitters","volume":"120","author":"Roth","year":"1992","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0378-1119(90)90231-F","article-title":"Molecular cloning and characterization of rat liver catechol-O-methyltransferase","volume":"93","author":"Salminen","year":"1990","journal-title":"Gene"},{"key":"10.1016\/S0006-8993(99)01063-X_BIB35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/dna.1993.12.253","article-title":"Structure of the rat catechol-O-methyltransferase gene: separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme","volume":"12","author":"Tenhunen","year":"1993","journal-title":"DNA Cell Biol."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/bj2960595","article-title":"Production of rat soluble and membrane-bound catechol-O-methyltransferase forms from bifunctional mRNAs","volume":"296","author":"Tenhunen","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1432-1033.1992.tb17112.x","article-title":"Expression of recombinant soluble and membrane-bound catechol-O-methyltransferase in eukaryotic cells and identification of the respective enzymes in rat brain","volume":"207","author":"Tilgmann","year":"1992","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB38","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1139\/o77-164","article-title":"Solubilization and partial purification of particulate catechol-O-methyltransferase from rat liver","volume":"55","author":"Tong","year":"1977","journal-title":"Can. J. Biochem."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB39","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1432-1033.1991.tb16464.x","article-title":"Cell-free synthesis of rat and human catechol-O-methyltransferase. Insertion of the membrane-bound form into microsomal membranes in vitro","volume":"202","author":"Ulmanen","year":"1991","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1432-1033.1997.0452a.x","article-title":"Expression and intracellular localization of catechol-O-methyltransferase in transfected mammalian cells","volume":"243","author":"Ulmanen","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB41","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1476-5381.1996.tb15220.x","article-title":"Ontogenic aspects of liver and kidney catechol-O-methyltransferase sensitivity to tolcapone","volume":"117","author":"Vieira-Coelho","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB42","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.49.3.665","article-title":"Tolcapone in stable Parkinson's disease: efficacy and safety of long-term treatment","volume":"49","author":"Waters","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/S0006-8993(99)01063-X_BIB43","first-page":"375","article-title":"Ro 40-7592: inhibition of COMT in rat brain and extracerebral tissues","volume":"32","author":"Z\u00fcrcher","year":"1990","journal-title":"J. Neural Trans."},{"key":"10.1016\/S0006-8993(99)01063-X_BIB44","first-page":"641","article-title":"Potent COMT inhibition by Ro 40-7592 in the periphery and in the brain. Preclinical and clinical findings","volume":"60","author":"Z\u00fcrcher","year":"1993","journal-title":"Adv. Neurol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689939901063X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689939901063X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T09:19:02Z","timestamp":1620465542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000689939901063X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["S000689939901063X"],"URL":"https:\/\/doi.org\/10.1016\/s0006-8993(99)01063-x","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[1999,3]]}}}